Osteoporosis is largely preventable. Eating a well- balanced diet, consuming calcium rich foods and avoiding toxins from smoke, alcohol and caffeine greatly reduce ones chances of developing this disease.
How do most osteoporosis medications work?
Medication for the treatment of Osteoporosis
Bisphosphonates are typically prescribed for osteoporosis. They work by decreasing the activity of bone-dissolving cells. Bisphosphonates slow down the process of bone breakdown that occurs as you age.
Zoledronic acid (Reclast)
Typical side effects from Osteoporosis Medication:
- flu symptoms
- muscular pain
- joint pain
Alternative treatments for Osteoporosis
- Vitamin D
- Green Tea
- Regular Exercise
- Calcium and Magnesium
With the exception of teriparatide, osteoporosis drugs slow bone breakdown. Healthy bones continuously break down and rebuild. As you age and, for women, especially after menopause, bones break down faster. Because bone rebuilding cannot keep pace, bones deteriorate and become weaker.
Osteoporosis medications put a brake on the process. These drugs maintain bone density and decrease the risk of breaking a bone as a result of osteoporosis.
Medical cannabis treatment for osteoporosis.
The Endocannabinoid System and Osteoporosis
- CB1, CB2, TRPV1 and GPR55 receptors are known to be found in the skeleton
- CB1 receptors are found on nerve fibres intervening bone as well as cells in the bone marrow
- CB1 receptors are also found on osteoblasts, osteoclasts and bone marrow derived adipocytes
- Osteoclasts, osteoblasts and osteocytes also express CB2 receptors at significantly higher levels than those reported for CB1
In 2009, there was a group of researchers from the University of Edinburgh (UK) who published a study in the journal Cell Metabolism. Their study suggests that activation of the CB1 receptor is primarily responsible for the benefits of cannabis in treating osteoporosis.
The University of Edinburgh research team investigated whether the endocannabinoid system (ECS) plays a role in osteoporosis as a condition. The team used two groups of mice in their study, one of which included rodents who had no CB1 receptors. The findings were rather interesting, in that the mice who were absent of CB1 receptors were the ones suffering from age-related osteoporosis, despite an increase in bone mass.
Lead author in the study, Ayman Idris, Ph. D explains: “the CB1 receptor is therefore unique in that it regulates peak bone mass through an effect on osteoclast activity, but protects against age-related bone loss by regulating adipocyte and osteoblast differentiation of bone marrow stromal cells.”
Statistics Osteoporosis in Australia
Osteoporosis and low bone density (osteopenia) are common in Australia. Minimal trauma fractures resulting from osteoporosis are also common. Generally, osteoporosis is under-diagnosed and the prevalence of the disease is expected to increase over the next decade.
4.74 million Australians over 50 have osteoporosis or poor bone health.
There is one fracture every 3.6 minutes in Australia (2013). By 2022, there will be one split every 2.9 minutes.
144,000 fractures occurred due to osteoporosis or osteopenia in 2013.
Over the next 10 years, the total cost of osteoporosis and associated fractures is estimated to be $33.6 billion.